Introduction

Prostate cancer is one of the most common cancers affecting men worldwide and remains a significant public health concern. Although many men diagnosed with prostate cancer survive for years with appropriate treatment and monitoring, the disease continues to contribute to illness and mortality, particularly when diagnosed at an advanced stage.

The prostate is a small gland found only in men. Located below the bladder and surrounding part of the urethra, it plays an important role in male reproductive health by producing fluid that nourishes and transports sperm. As men age, changes can occur within the prostate gland. Some of these changes are harmless, while others may lead to cancer.

Prostate cancer develops when abnormal cells within the prostate begin to grow uncontrollably. Some prostate cancers grow slowly and may not cause immediate problems, while others are aggressive and can spread to nearby tissues, bones, and other organs. Understanding the disease, recognising risk factors, and participating in appropriate screening programmes are essential for early detection and improved outcomes.

What is prostate cancer?

Prostate cancer occurs when abnormal cells develop within the prostate gland and multiply beyond normal control mechanisms. In many men, the cancer remains confined to the prostate for years. In others, it may spread through the blood or lymphatic system to distant parts of the body.

The seriousness of prostate cancer depends on factors such as the size of the tumour, how quickly it is growing, whether it has spread, the age of the patient, overall health status, and the stage at which it is diagnosed.

Global prevalence and demographic data

Prostate cancer is among the most frequently diagnosed cancers in men worldwide. Millions of new cases are reported annually, particularly in countries where screening programmes are widely available. The disease is strongly associated with ageing, making it increasingly common as life expectancy rises globally.

Age remains the most important risk factor. Prostate cancer is uncommon in men younger than 40 years but becomes increasingly prevalent after age 50. Most diagnoses occur in men aged 65 years and older, with the average age of diagnosis being approximately 66 years.

Research has also shown important racial and ethnic differences in prostate cancer occurrence. Men of African and Caribbean descent have higher rates of prostate cancer, are more likely to develop aggressive forms of the disease, and experience higher mortality rates. This makes prostate cancer awareness particularly important within African communities and among Black men globally.

In Africa, awareness and screening remain limited in many regions. Consequently, many men seek medical attention only when symptoms become severe, leading to delayed diagnosis and poorer outcomes. Factors contributing to late presentation include poor awareness, stigma, inadequate screening programmes, financial barriers, and limited access to specialist care.

Risk factors for prostate cancer

Several factors increase the likelihood of developing prostate cancer.

Age remains the strongest risk factor, with the disease becoming more common after the age of 50. Family history is also important. Men whose father or brother had prostate cancer have a greater risk, particularly if the relative was diagnosed at a younger age.

Ethnicity plays a significant role, with Black men experiencing a higher risk than many other populations. Lifestyle factors may also contribute. Obesity, smoking, excessive alcohol consumption, physical inactivity, and diets high in unhealthy fats have all been associated with increased risk.

Hormonal influences are another consideration. Male hormones such as testosterone may affect the growth and progression of prostate cancer cells.

Common symptoms of prostate cancer

One of the challenges of prostate cancer is that it often produces no symptoms during its early stages. This is why screening and routine health checks are so important.

As the disease progresses, symptoms may include difficulty passing urine, a weak urine stream, increased frequency of urination, waking frequently at night to urinate, blood in the urine, blood in semen, pain during urination, erectile dysfunction, and pelvic discomfort.

When prostate cancer spreads beyond the prostate gland, symptoms may become more severe. Advanced disease can cause persistent back pain, hip pain, bone weakness, unexplained weight loss, and fatigue.

It is important to remember that these symptoms do not automatically indicate prostate cancer. Other prostate conditions, including benign prostatic hyperplasia (BPH) and prostatitis, may produce similar symptoms. However, any persistent urinary or prostate-related symptoms should prompt medical assessment.

Importance of early detection

Early detection remains one of the most effective strategies for improving outcomes in prostate cancer. When diagnosed during the early stages, treatment options are broader, success rates are higher, complications are reduced, and survival rates improve significantly.

Many men diagnosed with localised prostate cancer can live long and healthy lives following appropriate treatment or monitoring. This highlights the value of regular screening and prompt medical evaluation of symptoms.

Prostate cancer screening

Screening aims to identify prostate abnormalities before symptoms become severe. It is particularly important for men over 50 years of age, Black men over 45 years of age, men with a family history of prostate cancer, and those experiencing urinary symptoms.

Healthcare professionals may recommend earlier screening for individuals considered to be at higher risk.

Prostate-Specific Antigen (PSA) Blood Test

The Prostate-Specific Antigen (PSA) blood test is one of the most widely used screening tools. PSA is a protein produced by the prostate gland, and elevated levels in the blood may indicate prostate cancer, prostate enlargement, inflammation, or infection.

A raised PSA level does not necessarily mean cancer is present, but it often prompts further investigations.

Digital Rectal Examination (DRE)

A Digital Rectal Examination involves a healthcare professional gently inserting a gloved finger into the rectum to assess the prostate gland. This allows the clinician to identify enlargement, lumps, hard areas, or other abnormalities.

Although some men may find the examination uncomfortable, it is quick and can provide valuable clinical information.

Multiparametric (mpMRI) scanning

Multiparametric MRI scans are increasingly used to identify suspicious areas within the prostate. MRI improves diagnostic accuracy and can help reduce unnecessary biopsies.

Prostate Biopsy

If PSA results or imaging studies suggest possible cancer, a biopsy may be performed. During this procedure, small tissue samples are taken from the prostate and examined under a microscope to confirm the presence or absence of cancer cells.

Stages of prostate cancer

Prostate cancer is classified according to how far it has spread within the region.  According to Cancer Research UK website  , there are ways to determine the stage such as the TNM, PSA, Gleason score

The four staging type is most common within the healthcare setting: 

Stage I: At this stage, the tumor is small, still enclosed to one small area of the prostate, and  rarely or cannot be felt during a digital rectal exam.

Stage II:  The stage two is when the cancer is still confined only to the prostate gland but bigger and can be seen  in more areas within the prostate.

Stage III (Locally Advanced): During this period, the  cancer has gone out of the prostate and may go into the nearby structures like the seminal vesicles.

Stage IV (Metastatic): Here, the cancer  is moving to the lymph nodes, bones, structures and other organs in the body

Treatment options

Treatment depends on several factors, including the stage of the cancer, its aggressiveness, the patient's age, overall health, and personal preferences.

Some men with slow-growing cancers may be managed through active surveillance, which involves regular monitoring without immediate treatment.

Surgical treatment may involve removal of the prostate gland, a procedure known as prostatectomy. Radiotherapy uses targeted radiation to destroy cancer cells, while hormone therapy reduces testosterone levels to slow cancer growth.

For advanced disease, chemotherapy and newer targeted therapies may be used. Advances in cancer treatment continue to improve outcomes and quality of life for many men living with prostate cancer.

Living with prostate cancer

A diagnosis of prostate cancer can have significant emotional, psychological, and physical effects. Men may experience anxiety, fear, depression, urinary difficulties, sexual health concerns, and relationship challenges.

Support from healthcare professionals, family members, counselling services, and cancer support groups can play an important role in helping individuals cope with diagnosis and treatment. Access to accurate information and emotional support often improves overall quality of life.

Prevention and healthy lifestyle choices

Although prostate cancer cannot always be prevented, certain lifestyle choices may help reduce risk. Maintaining a healthy weight, engaging in regular physical activity, eating a balanced diet rich in fruits and vegetables, reducing processed foods, avoiding smoking, and limiting alcohol intake are all recommended.

Regular health checks and awareness of prostate health remain important preventive measures, particularly for men at increased risk.

The importance of awareness

Many men avoid discussing prostate health because of embarrassment, fear, or cultural beliefs. Unfortunately, delayed presentation often results in more advanced disease at diagnosis.

Awareness campaigns encourage men to seek medical advice promptly, attend screening appointments, understand the symptoms of prostate disease, and take a proactive approach to their health.

Amongst the duties of the nurses in care of older persons is education which is an opportunity  for nurses caring for men aged 50 and above to educate them on prostate cancer.

Healthcare professionals also have an important role in educating communities and promoting early detection.

Conclusion

Prostate cancer remains one of the most common cancers affecting men worldwide, particularly older adults and men of African and Caribbean descent. Despite its seriousness, advances in screening, diagnosis, and treatment have significantly improved survival rates.

Understanding the symptoms, risk factors, demographic patterns, and available screening methods is essential for promoting awareness and encouraging early diagnosis. Men should not ignore urinary symptoms or avoid screening because of fear or embarrassment. Regular health assessments, particularly after the age of 50 or earlier for high-risk individuals, can help detect problems before complications develop.

Through increased awareness, routine screening, healthy lifestyle choices, and improved access to healthcare services, many lives can be protected from the devastating effects of advanced prostate cancer. This makes prostate cancer education and early detection one of the most important aspects of men's health today.